Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07061730 · ClinicalTrials.gov registry record · NA
Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
A NA study of Speech Sound Disorder, sponsored by Syracuse University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07061730: Recruiting NA study of Speech Sound Disorder, sponsored by Syracuse University.
NCT07061730 is a NA study of Speech Sound Disorder that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 120 participants, above the 81-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (48% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07061730, a NA study of Speech Sound Disorder, is actively recruiting participants, sponsored by Syracuse University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to determine whether the hybrid model improves articulation in children more effectively than traditional SLP-only therapy. Over the course of 8 weeks, participants will receive weekly therapy sessions, and those in the hybrid therapy group will also practice with Jessica between sessions. The study will also gather feedback from parents and speech therapists to assess their experiences and satisfaction with treatment.
Primary Outcome
Change scores from baseline to week 8 (i.e., after same amount of clinician treatment). Change scores are calculated from expert listener-averaged perceptual ratings of /ɹ/ or /s/ in pre-defined word lists. These ratings/words are solicited from the Outcome Word List. The ratings are obtained using Perceptual Rating Scale-5 point. Note: The Outcome Word List is not necessarily an untreated word list. Untreated words are ideal; however, it is not possible to ensure that words are untreated in a
Conditions Studied
Interventions
- BEHAVIORAL Traditional Therapy
- BEHAVIORAL Hybrid therapy
Study Locations (1)
New York
- Syracuse University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2026-02 |
| Phase | NA |
What NCT07061730 shows while recruiting
NCT07061730 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 81-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (48% higher).
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Traditional Therapy is the first listed.
NCT07061730 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07061730 about?
NCT07061730 is a clinical study titled "Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production". The purpose of this research study is to evaluate the effectiveness of a hybrid Artificial Intelligence-assisted speech therapy model, which combines the use of an AI speech therapist (Jessica) with traditional speech therapy sessions led by a Speech-Language Pathologist (SLP). This study aims to de...
What is the current status of trial NCT07061730?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-01. Estimated completion is 2026-02.
What conditions does trial NCT07061730 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT07061730?
The interventions under investigation include: Traditional Therapy (BEHAVIORAL), Hybrid therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07061730?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07061730 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07061730's enrollment target sits among peer trials
120 3rd of 15 higher than 13 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
RECRUITING · NA
-
Measuring Aided Language Development
RECRUITING · NA
-
BiOfeedback, Online for Sibilant Treatment
RECRUITING · NA
-
Treatment for /s/ Production Errors in Children With Speech Sound Errors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI